DeutschNewstral
Article
The Times of India on 2024-05-20 22:31
ICMR slams BHU's Covaxin study, says it wasn't part of it
Related news
- 'Poorly designed': ICMR distances itself from BHU's Covaxin studyThe Times of India
Better protection with Covishield-Covaxin combination: ICMRThe Hindu- Covaxin effective against Delta Plus variant: ICMRThe Times of India
- Study on Covaxin, Covishield mix shows better results, ICMR saysThe Times of India
- Covishield-Covaxin mix offers better shield, says ICMR studyThe Times of India
- Mixing Covaxin and Covishield is safe and effective: ICMRThe Times of India
- Delta variants lineages reduces Covaxin antibodies, ICMR studyThe Hindu
- Covaxin development has proved India is more than pharmacy of world: ICMR chiefThe Hindu
- COVID-19 | Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR studyThe Hindu
- ICMR to get royalty from Covaxin saleThe Hindu
- ICMR trashes claim it overpaid for test kitsThe Times of India
- It wasn't part of plan: Harmanpreet on controversial run outThe Times of India
- Mix and match of Covishield and Covaxin safe, more effective: ICMR studyThe Times of India
- Covid-19: Why 50% Covaxin efficacy may not be as bad as it seemsThe Times of India
- Australia recognises CovaxinThe Times of India
- ICMR isolates monkeypox virus, invites bids for jabsThe Times of India
'It wasn't about the turban'NZ Herald- Coronavirus | ICMR completes second sero-surveyThe Hindu
- ICMR revises Covid-19 testing strategyThe Times of India
- Scientists seek better access to ICMR dataThe Hindu